1. Meng XY, Liu J, Lv F, Liu MQ, Wan JM. Study on the correlation between extracellular matrix protein-1 and the growth, metastasis and angiogenesis of laryngeal carcinoma. Asian Pac J Cancer Prev. 2015; 16(6):2313-2316. doi:10.7314/APJCP.2015.16.6.2313
2. Lionello M, Staffieri A, Marioni G. Potential prognostic and therapeutic role for angiogenesis markers in laryngeal carcinoma. Acta Otolaryngol. 2012;132(6):574-582. doi:10.3109/00016489.2011.652308
3. Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene. 2003;22(42):6557-6563. doi:10. 1038/sj.onc.1206813
4. Zvrko E, Mikic A, Vuckovic L. CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2009;266(12):1971-1976. doi:10.1007/s 00405-009-0962-3
5. Szafarowski T, Sierdzinski J, Szczepanski MJ, Whiteside TL, Ludwig N, Krzeski A. Microvessel density in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2018;275(7):1845-1851. doi:10. 1007/s00405-018-4996-2
6. Lazaris ACh, Lendari I, Kavantzas N, Kandiloros D, Adamopoulos G, Davaris P. Correlation of tumor markers p53, bcl-2 and cathepsin-D with clinicopathologic features and disease-free survival in laryngeal squamous cell carcinoma. Pathol Int. 2000;50(9):717-724. doi:10.1046/j. 1440-1827.2000.01110.x
7. Kupisz K, Chibowski D, Klatka J, Klonowski S, Stepulak A. Tumor angiogenesis in patients with laryngeal cancer. Eur Arch Otorhinolaryngol. 1999;256(6):303-305. doi:10.1007/s004050050251
8. Beatrice F, Cammarota R, Giordano C, et al. Angiogenesis: prognostic significance in laryngeal cancer. Anticancer Res. 1998;18(6B):4737-4740.
9. Burian M, Quint C, Neuchrist C. Angiogenic factors in laryngeal carcinomas: do they have prognostic relevance?Acta Otolaryngol. 1999; 119(2):289-292. doi:10.1080/00016489950181846
10. Hagedorn HG, Nerlich AG. Microvessel density and endothelial basement membrane composition in laryngeal squamous cell carcinomas. Acta Otolaryngol. 2000;120(7):891-898. doi:10.1080/ 000164800750061796
11. Sarbia M, Bittinger F, Porschen R, Dutkowski P, Willers R, Gabbert HE. Tumor vascularization and prognosis in squamous cell carcinomas of the esophagus. Anticancer Res. 1996;16(4A):2117-2121.
12. MacLennan GT, Bostwick DG. Microvessel density in renal cell carcinoma: lack of prognostic significance. Urology. 1995;46(1):27-30. doi:10.1016/S0090-4295(99)80153-8
13. Dray TG, Hardin NJ, Sofferman RA. Angiogenesis as a prognostic marker in early head and neck cancer. Ann Otol Rhinol Laryngol. 1995; 104(9):724-729. doi:10.1177/000348949510400911
14. Murray JD, Carlson GW, McLaughlin K, et al. Tumor angiogenesis as a prognostic factor in laryngeal cancer.Am J Surg. 1997;174(5):523-526. doi:10.1016/s0002-9610(97)00168-2
15. Marioni G, D’Alessandro E, Giacomelli L, Staffieri A. CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma. J Oral Pathol Med. 2010;39(5):361-367. doi:10.1111/j.1600-0714.2010.00888.x
16. Shpitzer T, Chaimoff M, Gal R, Stern Y, Feinmesser R, Segal K. Tumor angiogenesis as a prognostic factor in early oral tongue cancer Arch Otolaryngol Head Neck Surg. 1996;122;(8):865-868.doi:10.1001/archotol.1996.01890200055012
17. Schimming R, Marmé D. Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity.Head Neck. 2002;24(2):151-156. doi:10. 1002/hed.10040